The IgG antibody levels directed against fHbp and NadA, two potential vaccine antigens for Neisseria meningitidis, were examined in order to investigate the extent of natural immunisation against these antigens in different age groups. As a comparison, the IgG antibody levels against Haemophilus influenzae type b were examined. In the two youngest age groups, below 10 years of age, relatively low levels of both anti-fHbp and anti-NadA were measured. A 15-fold higher geometric mean concentration of anti-fHbp was noted in the age group 20-29 years as compared to the age group 15-19 years. The peak concentration was found at 30-39 years, followed by decreased levels with age. Anti-NadA showed a certain increase up to 9 years followed by an even increase up to 40-49 years.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.vaccine.2009.07.056 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Bartholinitis due to Neisseria meningitidis: Clinical case].
Rev Argent Microbiol
November 2024
Laboratorio Nacional de Referencia de Meningitis e Infecciones Respiratorias Bacterianas, Servicio Bacteriología Clínica, INEI-ANLIS «Dr. Carlos G. Malbrán», Ciudad Autónoma de Buenos Aires, Argentina.
Bartholinitis is the inflammation and infection of the Bartholin's glands that results from the accumulation of mucus in their ducts, the most frequent causal microorganisms being anaerobic and aerobic bacteria and those responsible for sexually transmitted infections. Those caused by agents not belonging to the genital microbiota are less frequent. Likewise, in most cases the diagnosis is clinical.
View Article and Find Full Text PDFNHBA antibodies elicited by 4CMenB vaccination are key for serum bactericidal activity against Neisseria gonorrhoeae.
NPJ Vaccines
November 2024
Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
The 4CMenB (Bexsero) vaccine contains detergent-extracted outer membrane vesicles (OMVs) from a Neisseria meningitidis (Nm) group B strain NZ98/254 and three recombinant Nm protein antigens: Neisseria adhesin A (NadA), Factor H binding protein (FHbp, as the C-terminal protein in the GNA2091-FHbp fusion), and Neisserial Heparin Binding Antigen (NHBA, as the N-terminal protein in the NHBA-GNA1030 fusion). Previous work has shown that 4CMenB generates serum antibodies to Nm and Neisseria gonorrhoeae (Ng) OMV proteins and lipooligosaccharide (LOS). Mounting evidence indicates 4CMenB can partially protect against mucosal infections with Ng.
View Article and Find Full Text PDFCharacterisation and Immunogenicity of outer membrane vesicles displaying NadA, NHBA and fHbp from serogroup B.
Front Immunol
October 2024
Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Article Synopsis
- There is a need for more affordable and effective vaccines to prevent bacterial meningitis caused by serogroup B globally.
- The study explores the use of modified outer membrane vesicles (mOMVs) from commensal bacteria to elicit immune responses against meningococcal antigens, specifically various versions of factor H binding protein, Heparin Binding Antigen, and Adhesin A.
- The results showed that mice immunized with these engineered mOMVs produced antibodies to all targeted antigens and demonstrated significant serum bactericidal activity, indicating the potential of mOMVs for developing a protective vaccine against meningococcal disease.
Whole-genome sequencing of Neisseria meningitidis collected in Chile from pediatric patients during 2016-2019 and coverage vaccine prediction.
Vaccine
December 2024
Department of Pediatrics, Faculty of Medicine, Universidad de Chile, 8380453, Chile; Infectious Diseases Unit, Hospital de niños Dr. Luis Calvo Mackenna, 7500000, Chile. Electronic address:
Article Synopsis
- This study examined the genetic makeup of Neisseria meningitidis strains from Chilean children using whole-genome sequencing (WGS) to assess potential vaccine effectiveness.* -
- Out of 42 strains analyzed, the most common types were MenB and MenW, with findings indicating varying levels of predicted vaccine coverage using tools like gMATS and MenDeVAR.* -
- The results revealed significant genetic variability among Chilean strains compared to those in other countries, which limits the ability to predict vaccine coverage accurately with existing methods.*
Genetic characterization and estimated 4CMenB vaccine strain coverage of 284 isolates causing invasive meningococcal disease in Argentina in 2010-2014.
Hum Vaccin Immunother
December 2024
Instituto Nacional de Enfermedades Infecciosas-ANLIS "Dr. Carlos G. Malbrán", Buenos Aires, Argentina.
Article Synopsis
- The study investigates the diversity of Meningococcal serogroup B (MenB) strains in Argentina and assesses vaccine coverage using genetic tools like gMATS and human serum bactericidal antibodies (hSBA).
- Researchers analyzed 284 MenB isolates, identifying that the four main clonal complexes represented over 81% of the samples, with varying antigen profiles for vaccine candidates.
- Results showed that the 4CMenB vaccine could potentially cover approximately 61.3% of strains based on gMATS predictions and 78.4% based on hSBA assay, highlighting the need for ongoing genomic monitoring of MenB in Argentina.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!